MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Distinct patterns of Gene Expression in Skin-biopsy Derived Fibroblasts of Patients with Parkinson’s disease

    T. Ntetsika, I. Markaki, A. Damdimopoulos, M. Zeitelhofer, P. Tsitsi, M. Zeitelhofer Adzemovic, P. Svenningsson (Stockholm, Sweden)

    Objective: In this study, we aimed to investigate global gene expression alterations in cultured skin fibroblasts from individuals with idiopathic Parkinson’s disease (PD) compared to…
  • 2024 International Congress

    Studying monogenic Parkinson’s disease by building a global cohort of mutation carriers

    L. Lange, J. Junker, E-J. Vollstedt, K. Roopnarain, M. Doquenia, A. Ahmad-Annuar, M. Avenali, S. Bardien, N. Bahr, M. Ellis, C. Galandra, T. Gasser, P. Heutink, A. Illarionova, Y. Kanana, I. Keller Sarmiento, K. Kumar, S-Y. Lim, H. Madoev, I. Mata, N. Mencacci, M. Nalls, S. Padmanabhan, C. Shambetova, J. Solle, A-H. Tan, J. Trinh, E M. Valente, A. Singleton, C. Blauwendraat, K. Lohmann, Z-H. Fang, C. Klein (Luebeck, Germany)

    Objective: ObjectiveTo build a multi-ancestry cohort of individuals with pathogenic variants in genes known to cause Parkinson’s disease (PD) to study monogenic PD at a…
  • 2024 International Congress

    RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD)

    C. Beetz, M. Radefeldt, K. Tripolszki, P. Bauer (Rostock, Germany)

    Objective: To identify and characterize PD patients with RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD; ClinicalTrials.gov NCT03866603). Background: A recent preprint provided…
  • 2024 International Congress

    Screening for newly PD-associated RAB32 p.S71R variant in Latin America

    M. Rivera Paz, E. Waldo, T. Leal, P. Reyes-Pérez, M. Inca-Martinez, S. Alcauter, I. Amorín, M. Cornejo-Olivas, E. Dieguez, I. Estrada-Bellmann, A. Hernández-Medrano, M. Jimenez-Del-Rio, A. Lescano, B. Muñoz Ospina, K. Nuytemans, J. Orozco, V. Raggio, M. Rentería, J. Rios-Pinto, M. Rodriguez-Violante, K. Salinas Barboza, A. Schuh, C. Velez-Pardo, I. Mata (Cleveland, USA)

    Objective: Our aim was to identify whether a novel putative pathogenic variant in RAB32, a gene recently associated with familial forms of Parkinson’s Disease (PD),…
  • 2024 International Congress

    DPPX Autoimmune Encephalitis Associated with Severe Multifocal Dystonia.

    E. Roddy, E. Gentry, P. Hedera, V. Holiday, D. Robertson (LOUISVILLE, USA)

    Objective: To describe a novel motor phenomenology in an individual diagnosed with anti-DPPX encephalitis at our institution and to compare it with previously known phenotypic…
  • 2024 International Congress

    Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease

    C. Guedes Vaz, H. Pessegueiro, J. Castro Ferreira, J. Gandara, V. Dionísio Lopes, E. Silva, S. Ferreira, C. Pereira, D. Valadares, L. Maia, J. Presa, A. Pinto, A. Costa, C. Rolanda, C. Agostinho, I. Gonçalves, P. Peixoto, R. Costa, S. Lopes, M. Magalhães (Porto, Portugal)

    Objective: To determine the frequency of side effects of long-term copper chelation therapy in Wilson’s disease (WD). Background: WD is a neurometabolic autosomal recessive disorder…
  • 2024 International Congress

    Movement-Related Potentials Recorded Using Cerebellar Deep Brain Stimulation Leads

    U. Saha, T. Grippe, Y. Lin, M. Callister, G. Sorrento, J. Nankoo, R. Munhoz, A. Fasano, S. Kalia, R. Chen (Toronto, Canada)

    Objective: Investigate cerebellar local field potentials (LFPs) associated with movement using DBS leads in patients with spinocerebellar ataxia. Background: The Bereitschaftspotential (BP) detectable via EEG…
  • 2024 International Congress

    Altered levels of interleukin-6 in Parkinson’s disease patients with and without Covid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: Scientists say that the infectious agent SARS-CoV-2 increases the…
  • 2024 International Congress

    Case Studies of Real-World Brain Sensing Showing Patient-Specific Trends to Inform Therapy Management in Parkinson’s Disease

    A. Nourmohammadi, E. Fehrmann, A. Holt-Becker, R. Raike (New Brighton, USA)

    Objective: Explore the utility of chronic brain sensing in identifying patient-specific trends that could be useful to tailor deep brain stimulation (DBS) in Parkinson’s disease…
  • 2024 International Congress

    Exploring the Therapeutic Potential of Microglial Modulation in Parkinson’s Disease: A Study on Structural Synaptic Plasticity

    F. Fares Taie, I. Taravini, L. Rela (Buenos Aires, Argentina)

    Objective: We aim to explore the role of glial cells in Parkinson's disease and assess whether modulating microgliafunction could offer therapeutic benefits. Specifically, we investigate…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley